| Autor: |
Raddatz, Peter, Gante, Joachim |
| Zdroj: |
Expert Opinion on Therapeutic Patents; November 1995, Vol. 5 Issue: 11 p1165-1183, 19p |
| Abstrakt: |
Platelet adhesion and aggregation, which have been identified as promising targets for the development of antithrombotic drugs, are mediated by a family of glycoprotein receptors. Antagonists of the most important of these receptors, Gpllb/llla, are currently under investigation for a range of both cardiovascular and cerebrovascular disorders. This article aims to compare data for existing Gpllb/llla antagonists in various stages of clinical development, with those compounds which appear in the recent patent literature. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
